205 related articles for article (PubMed ID: 2683255)
1. Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.
Brettfeld C; Gobrogge R; Massoud N; Munzenberger P; Nigro M; Sarnaik A
Ther Drug Monit; 1989 Sep; 11(5):612-5. PubMed ID: 2683255
[TBL] [Abstract][Full Text] [Related]
2. Phenytoin and phenobarbital concentrations in serum: a comparison of Ames Seralyzer with GLC, TDX, and EMIT.
Leppik IE; Oles KS; Sheehan ML; Penry JK; Parker DR; Gallagher TK; Caron GP; Rosenfeld W; Salmon JJ
Ther Drug Monit; 1989; 11(1):73-8. PubMed ID: 2643204
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Seralyzer and EMIT systems for determination of theophylline concentrations.
Massoud N; Munzenberger P; Sarniak A
Am J Hosp Pharm; 1986 Jul; 43(7):1722-6. PubMed ID: 3529948
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of phenytoin and phenobarbital in capillary blood by Ames Seralyzer.
Graves NM; Holmes GB; Leppik IE; Galligher TK; Parker DR
Epilepsia; 1987; 28(6):713-6. PubMed ID: 3691418
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Ames Seralyzer for therapeutic drug monitoring of phenobarbital and phenytoin.
Brettfeld C; Massoud N; Munzenberger P; Nigro M; Sarnaik A; Gobrogge R
Clin Chem; 1989 Feb; 35(2):324. PubMed ID: 2914388
[No Abstract] [Full Text] [Related]
6. Evaluation of the Ames Seralyzer for therapeutic drug monitoring of theophylline.
Vaughan LM; Weinberger MM; Milavetz G
Drug Intell Clin Pharm; 1986 Feb; 20(2):118-21. PubMed ID: 3512223
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of determination of theophylline concentrations by Seralyzer.
Nguyen QC; Sly RM; Boeckx RL; Kelly HA
Ann Allergy; 1986 Aug; 57(2):147-9. PubMed ID: 3526988
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Seralyzer reflectance photometer theophylline assay and an Emit assay.
Singh P; Lim DT; Enright T; de la Cruz RY; Noutsis S; Lim AT; Mariano R; Chakrin AL
Ann Allergy; 1987 Sep; 59(3):176-8. PubMed ID: 3307546
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in saliva.
Miles MV; Tennison MB; Greenwood RS; Benoit SE; Thorn MD; Messenheimer JA; Ehle AL
Ther Drug Monit; 1990 Sep; 12(5):501-10. PubMed ID: 2293415
[TBL] [Abstract][Full Text] [Related]
10. Application of the Abbott TDx lidocaine, phenytoin, and phenobarbital assays to postmortem blood specimens.
Caplan YH; Levine B
J Anal Toxicol; 1988; 12(5):265-7. PubMed ID: 3066993
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Abbott TDx for the stat measurement of phenobarbital, phenytoin, carbamazepine, and theophylline.
Loomis KF; Frye RM
Am J Clin Pathol; 1983 Nov; 80(5):686-91. PubMed ID: 6637881
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of drug therapy in epileptic children.
Singh LM; Mehta S; Vohra RM; Nain CK
Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):251-4. PubMed ID: 3596850
[TBL] [Abstract][Full Text] [Related]
13. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Matheke ML; Valdes R
Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
Farnbach GC
J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
[TBL] [Abstract][Full Text] [Related]
15. Dry reagent immunoassay for measuring phenobarbital in serum and plasma.
Sommer R; Clayborn J; Thompson S; Greenquist A
Ther Drug Monit; 1988; 10(2):197-204. PubMed ID: 3381239
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
Sedman AJ; Molitoris BA; Nakata LM; Gal J
Am J Nephrol; 1986; 6(2):132-4. PubMed ID: 3085501
[TBL] [Abstract][Full Text] [Related]
17. Cost-effective assays for use in monitoring carbamazepine, phenobarbital, and phenytoin in serum.
Moore FM; Simpson D
Clin Chem; 1989 Aug; 35(8):1782-4. PubMed ID: 2503270
[TBL] [Abstract][Full Text] [Related]
18. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
Liappis N
Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
[TBL] [Abstract][Full Text] [Related]
19. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
Battino D; Croci D; Mamoli D; Messina S; Perucca E
Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for the quantitative determination of phenytoin, phenobarbitone and carbamazepine in serum.
Ashy AR; el-Sayed YM; Islam SI
J Pharm Pharmacol; 1986 Aug; 38(8):572-7. PubMed ID: 2876072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
